1. Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia;Bloomfield, C.D.; Secker-Walker, L.M.; Goldman, A.I.;Cancer Genet Cytogenet,1989
2. Morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations;Bennett, J.M.; Catovsky, D.; Daniel, M.T.;Br J Haematol,1981
3. Design and analysis of randomised clinical trials requiring prolonged observation of each patient;Peto, R.; Pike, M.C.; Armitage, P.;Br J Cancer,1977
4. Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia;Pui, C.-H.; Williams, D.L.; Roberson, P.K.;J Clin Oncol,1988
5. Balanced and unbalanced 1;Shikano, T.; Kaneko, Y.; Takazawa, M.; Ueno, N.; Ohkawa, M.; Fujimoto, T.;Cancer; translocationassociated acute lymphoblastic leukemias,1986